RXPLATINUM Trademark

Trademark Overview

On Thursday, March 12, 2020, a trademark application was filed for RXPLATINUM with the United States Patent and Trademark Office. The USPTO has given the RXPLATINUM trademark a serial number of 88831984. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 25, 2022. This trademark is owned by RxSense LLC. The RXPLATINUM trademark is filed in the Advertising, Business and Retail Services category with the following description:

Administration of a consumer prescription drug discount program for enabling participants to obtain discounts on prescriptions through use of a discount card
rxplatinum

General Information

Serial Number88831984
Word MarkRXPLATINUM
Filing DateThursday, March 12, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesAdministration of a consumer prescription drug discount program for enabling participants to obtain discounts on prescriptions through use of a discount card

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 18, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRxSense LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02110
Party NameRxSense LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Monday, April 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU EXTENSION 2 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 2 FILED
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 20, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 16, 2021SOU EXTENSION 1 GRANTED
Tuesday, March 16, 2021SOU EXTENSION 1 FILED
Tuesday, March 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 18, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, June 17, 2020ASSIGNED TO LIE
Wednesday, June 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 17, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, June 17, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, June 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 15, 2020NON-FINAL ACTION E-MAILED
Monday, June 15, 2020NON-FINAL ACTION WRITTEN
Thursday, June 4, 2020ASSIGNED TO EXAMINER
Wednesday, March 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 16, 2020NEW APPLICATION ENTERED

Related Keywords

rxplatinum discount discounts obtain prescriptions card through participants enabling consumer prescription